Busatto, G F <br/><br/>
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.  [electronic resource] 

 -  Psychopharmacology  Jan 1995 
 - 55-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0033-3158 
<br/><br/><label>Standard No.: </label>10.1007/BF02245098  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antipsychotic Agents--pharmacology<br/>Basal Ganglia--metabolism<br/>Benzamides<br/>Cerebral Cortex--metabolism<br/>Dopamine D2 Receptor Antagonists<br/>Female<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Iodine Radioisotopes<br/>Isoxazoles--pharmacology<br/>Male<br/>Middle Aged<br/>Neostriatum--anatomy & histology<br/>Piperidines--pharmacology<br/>Psychiatric Status Rating Scales<br/>Psychotic Disorders--drug therapy<br/>Pyrrolidines<br/>Remoxipride--pharmacology<br/>Risperidone<br/>Schizophrenia--drug therapy<br/>Tomography, Emission-Computed, Single-Photon